These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 21728970)

  • 1. Pharmacotherapy of borderline personality disorder: a systematic review for publication purpose.
    Bellino S; Rinaldi C; Bozzatello P; Bogetto F
    Curr Med Chem; 2011; 18(22):3322-9. PubMed ID: 21728970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological interventions for borderline personality disorder.
    Stoffers J; Völlm BA; Rücker G; Timmer A; Huband N; Lieb K
    Cochrane Database Syst Rev; 2010 Jun; (6):CD005653. PubMed ID: 20556762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of pharmacotherapy for severe personality disorders: meta-analyses of randomized controlled trials.
    Ingenhoven T; Lafay P; Rinne T; Passchier J; Duivenvoorden H
    J Clin Psychiatry; 2010 Jan; 71(1):14-25. PubMed ID: 19778496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of pharmacotherapies for borderline personality disorder.
    Bellino S; Paradiso E; Bogetto F
    CNS Drugs; 2008; 22(8):671-92. PubMed ID: 18601305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms.
    Mercer D; Douglass AB; Links PS
    J Pers Disord; 2009 Apr; 23(2):156-74. PubMed ID: 19379093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotics, antidepressants, anticonvulsants, and placebo on the symptom dimensions of borderline personality disorder: a meta-analysis of randomized controlled and open-label trials.
    Vita A; De Peri L; Sacchetti E
    J Clin Psychopharmacol; 2011 Oct; 31(5):613-24. PubMed ID: 21869691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effectiveness of antipsychotics in borderline personality disorder: meta-analyses of placebo-controlled, randomized clinical trials on symptomatic outcome domains.
    Ingenhoven TJ; Duivenvoorden HJ
    J Clin Psychopharmacol; 2011 Aug; 31(4):489-96. PubMed ID: 21694626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamotrigine as a promising approach to borderline personality: an open case series without concurrent DSM-IV major mood disorder.
    Pinto OC; Akiskal HS
    J Affect Disord; 1998 Dec; 51(3):333-43. PubMed ID: 10333987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials.
    Lieb K; Völlm B; Rücker G; Timmer A; Stoffers JM
    Br J Psychiatry; 2010 Jan; 196(1):4-12. PubMed ID: 20044651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy of borderline personality disorder: replacing confusion with prudent pragmatism.
    Starcevic V; Janca A
    Curr Opin Psychiatry; 2018 Jan; 31(1):69-73. PubMed ID: 29028643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marine Omega-3 Fatty Acid Supplementation for Borderline Personality Disorder: A Meta-Analysis.
    Karaszewska DM; Ingenhoven T; Mocking RJT
    J Clin Psychiatry; 2021 May; 82(3):. PubMed ID: 34004088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Clinical Psychopharmacology in Borderline Personality Disorder.
    Del Casale A; Bonanni L; Bargagna P; Novelli F; Fiaschè F; Paolini M; Forcina F; Anibaldi G; Cortese FN; Iannuccelli A; Adriani B; Brugnoli R; Girardi P; Paris J; Pompili M
    Curr Neuropharmacol; 2021; 19(10):1760-1779. PubMed ID: 34151763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy for borderline personality disorder--current evidence and recent trends.
    Stoffers JM; Lieb K
    Curr Psychiatry Rep; 2015 Jan; 17(1):534. PubMed ID: 25413640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials.
    Nosè M; Cipriani A; Biancosino B; Grassi L; Barbui C
    Int Clin Psychopharmacol; 2006 Nov; 21(6):345-53. PubMed ID: 17012981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacotherapy effectiveness for some symptoms of borderline personality disorder].
    Benjaminsen S
    Ugeskr Laeger; 2014 Sep; 176(36):. PubMed ID: 25293847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidenced-based pharmacologic treatment of borderline personality disorder: a shift from SSRIs to anticonvulsants and atypical antipsychotics?
    Abraham PF; Calabrese JR
    J Affect Disord; 2008 Nov; 111(1):21-30. PubMed ID: 18304647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
    Munch G; Godart N
    Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and emerging medications for borderline personality disorder: is pharmacotherapy alone enough?
    Bozzatello P; Rocca P; De Rosa ML; Bellino S
    Expert Opin Pharmacother; 2020 Jan; 21(1):47-61. PubMed ID: 31693423
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug therapy of patients with emotionally unstable personality].
    Nissen T
    Tidsskr Nor Laegeforen; 2000 Aug; 120(18):2135-41. PubMed ID: 11006733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological interventions for people with borderline personality disorder.
    Binks CA; Fenton M; McCarthy L; Lee T; Adams CE; Duggan C
    Cochrane Database Syst Rev; 2006 Jan; (1):CD005653. PubMed ID: 16437535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.